SCLN
SciClone Pharmaceuticals: A
revenue-generating, specialty pharmaceutical company
with a substantial commercial business in China and a product portfolio
spanning major therapeutic markets including oncology, infectious diseases
and cardiovascular disorders.More.

OMER
Omeros Corp.: A clinical-stage biopharmaceutical company committed to discovering,
developing and commercializing products targeting inflammation,
coagulopathies and disorders of the central nervous system. Omeros
has five clinical development programs.More.

ICPT
Intercept Pharmaceuticals: A biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat orphan and more prevalent
liver diseases utilizing its expertise in bile acid chemistry. OCA has received orphan drug
designation in both the United States and Europe for the treatment of PBC.More.

Subscribers to our Free newsletter will receive stock reports and news alerts for small-cap stocks
via email. You can sign-uphere.

"A Primer In Microcap
Investing"

SmallCapReview.com®is a leading destination for small-cap picks and news. The Purpose of
SmallCapReview.com is to profile and bring awareness to companies with a market cap of
less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap and penny
stocks to watch via various newswires. We will strive to bring you the
undiscovered, the undervalued, and the oversold. SmallCapReview.comdoes not give "buy" recommendations, price targets nor
suggest entry and exit points.